Cancer drugs Current Affairs, GK & News
On December 18, 2019, the World Health Organization launched its first biosimilar medicine to treat breast cancer. The WHO intends to make the expensive, life-saving treatment affordable for women all over the world. Highlights WHO launched a biosimilar medicine “Trastuzumab” in order to treat breast cancers. It is an antibody that shows high efficacy in ..
Category: International Current Affairs
The National Pharmaceutical Pricing Authority (NPPA) has slashed the prices of 9 non-scheduled cancer drugs by up to 87 per cent as part of its efforts to bring down drugs prices. The move is expected to curb profiteering on these vital drugs and to make cancer cure affordable for patients and their families. National Pharmaceutical Pricing ..
The National Pharmaceutical Pricing Authority (NPPA) has reduced the prices of 9 non-scheduled cancer drugs by up to 87%. This decision is in continuation of nodal agency’s efforts to bring down drugs prices. Key Facts Reason: In February 2019, the government had capped about 42 cancer drugs at 30%. This new anti-cancer non-scheduled medicine list ..
Month: Current Affairs - May, 2019
Category: Economy & Banking Current Affairs
Topics: Anti-cancer drugs • Cancer drugs • Department of Pharmaceuticals • Drug Price Control Orders • Drug Pricing • Ministry of Chemicals & Fertilizers • national list of essential medicines • National Pharmaceutical Pricing Authority • NLEM • NPPA
The National Pharmaceutical Pricing Authority (NPPA) has reduced the MRP of 390 non-scheduled cancer medicines have been reduced by up to 87%. NPA has asked the manufacturers and hospitals to revise the prices based on the trade margin formula. The release by the NPPA states that five brands will see a price reduction of about ..